This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Motor neuron disease (with DMD)
MND
muscular disease: Acquired, familial, and congenital disorders of skeletal muscle and smooth muscle.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
31 |
4. Check minimum number of eventsNone |
31 |
5. Include endpoints |
790 |
6. Filter based on genotype QC (FinnGen only) |
776 |
Extra metadata
- First used in FinnGen datafreeze
- DF3
- Parent code in ICD-10
- G710
- Name in latin
- Dystrophia musculorum gravis (Duchenne)
Similar endpoints
↥List of similar endpoints to
Motor neuron disease (with DMD)
based on the number of shared cases.
Similar with more cases:
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 776 | 315 | 461 |
| Unadjusted period prevalence (%) | 0.17 | 0.11 | 0.21 |
| Median age at first event (years) | 67.57 | 67.55 | 67.58 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 790
- Matched controls
- 7900
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
JDB10
NOMESCO Finland
Percutaneous gastrostomy
110.7
307.7
180
21
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
98.6
307.7
221
31
J96.1
ICD-10 Finland
Chronic respiratory failure
44.7
307.7
209
63
G12.2
ICD-10 Finland
Motor neuron disease
+∞
307.7
734
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
22.5
243.1
192
111
N07XX02
ATC
riluzole; oral
+∞
223.9
204
*
R13
ICD-10 Finland
Dysphagia
16.3
219.3
207
168
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
27.3
199.7
142
63
N99
ICPC
Neurological disease other
799.2
196.0
185
*
R4130
NOMESCO Finland
Speech therapy
43.7
191.2
116
31
Z51.5
ICD-10 Finland
Palliative care
10.3
189.8
258
354
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
20.5
183.4
148
88
TAB00
NOMESCO Finland
Lumbar puncture
41.0
183.3
113
32
R47.1
ICD-10 Finland
Dysarthria and anarthria
967.2
165.0
156
*
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
45.5
148.9
89
22
G47.3
ICD-10 Finland
Sleep apnoea
16.0
144.1
131
97
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
10.1
143.3
184
230
SPAT1229
SPAT
Assessment of need for aid
12.1
125.1
136
134
A28
ICPC
Limited function/disability NOS
6.5
123.4
257
544
XG466
NOMESCO Finland
Sleep oxymetry
26.3
123.1
87
37
R5140
NOMESCO Finland
Monitoring the use of the aid
13.3
114.4
115
100
R1250
NOMESCO Finland
Evaluation of functional capability
33.7
105.2
68
22
N03AE01
ATC
clonazepam; systemic
20.4
103.4
81
44
L28
ICPC
Limited function/disability (L)
5.8
101.2
230
520
N28
ICPC
Limited function/disability (N)
134.3
99.7
105
9
WX725
NOMESCO Finland
Noninvasive ventilation
9.3
99.5
131
166
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
43.0
92.8
56
14
N29
ICPC
Neurological sympt/complt other
54.5
89.1
51
10
R4120
NOMESCO Finland
Occupational therapy
10.0
88.8
108
123
R4190
NOMESCO Finland
Nutritional therapy
10.4
81.8
96
104
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
10.8
76.2
86
88
R1260
NOMESCO Finland
Evaluation of communicative skills
24.6
73.9
53
23
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
9.0
70.9
93
116
D21
ICPC
Swallowing problem
30.5
69.2
46
16
R5599
NOMESCO Finland
Other rehabilitation service
13.2
68.4
67
55
S06.0
ICD-10 Finland
Concussion
14.9
68.0
62
45
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
6.8
67.5
115
193
XA800
NOMESCO Finland
Neuropsychological investigation
34.9
67.4
43
13
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
4.7
66.6
185
483
N19
ICPC
Speech disorder
24.3
66.6
48
21
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
32.4
66.0
43
14
SPAT1231
SPAT
Assessment of adjustments needed in living environment
23.2
65.4
48
22
N02AA01
ATC
morphine; systemic, rectal
11.1
65.3
72
71
N05AH04
ATC
quetiapine; oral
8.8
63.8
84
105
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
10.9
61.9
69
69
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
8.2
61.3
86
116
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
20.3
59.3
46
24
AA1AD
NOMESCO Finland
CT of head and brain
4.2
58.3
185
531
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
26.3
57.2
40
16
G12.9
ICD-10 Finland
Spinal muscular atrophy, unspecified
+∞
57.0
54
*
N06AB10
ATC
escitalopram; oral
5.4
56.5
123
260
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
13.5
55.1
53
42
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
6.2
54.1
100
181
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
10.4
53.4
61
63
M03BX01
ATC
baclofen; systemic
71.9
53.0
60
9
N06AX11
ATC
mirtazapine; oral
3.6
52.6
220
761
SPAT1216
SPAT
Assessment of functional ability
4.2
51.6
160
449
XA402
NOMESCO Finland
ENMG
20.0
51.3
40
21
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
138.9
49.4
52
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
8.3
49.1
67
87
TJD20
NOMESCO Finland
Change of gastrostomy tube
81.2
47.6
53
7
SPAT1245
SPAT
Provision of support and information to patient’s family members
9.5
46.9
57
64
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.8
45.3
161
495
N18
ICPC
Paralysis/weakness
127.6
45.3
48
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
6.6
44.2
75
124
N05BA04
ATC
oxazepam; oral
3.6
44.2
180
606
F32.9
ICD-10 Finland
Depressive episode, unspecified
14.6
42.8
39
28
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.8
40.6
142
430
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
13.2
40.3
39
31
SPAT1215
SPAT
Assessment of need for medical rehabilitation
8.4
39.6
53
67
N05BA06
ATC
lorazepam; systemic, sublingual
8.0
39.5
55
73
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
110.8
39.1
42
*
SPAT1234
SPAT
Support of social functional capacity
7.4
36.9
55
79
G72.9
ICD-10 Finland
Myopathy, unspecified
+∞
35.7
34
*
R5110, ,
SPAT
5.0
35.1
80
174
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.8
33.8
114
335
F51.0
ICD-10 Finland
Nonorganic insomnia
+∞
33.6
32
*
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
58.5
33.5
39
7
N06AB04
ATC
citalopram; systemic
3.7
33.1
117
355
G71.06
ICD-10 Finland
Muscular dystrophy severe [Duchenne]
+∞
32.5
31
*
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
5.1
30.5
67
141
G12.8
ICD-10 Finland
Other spinal muscular atrophies and related syndromes
+∞
30.4
29
*
Z31.5
ICD-10 Finland
Genetic counselling
5.4
29.9
61
120
G56.0
ICD-10 Finland
Carpal tunnel syndrome
6.8
29.3
47
73
R25.3
ICD-10 Finland
Fasciculation
103.8
27.8
30
*
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
10.1
27.8
32
33
A06AD11
ATC
lactulose; oral
3.1
26.5
129
475
N02AA05
ATC
oxycodone; systemic
2.7
26.4
171
734
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
+∞
26.2
25
*
UDQ42
NOMESCO Finland
Endoscopic assessment of swallowing function
139.6
25.8
27
*
N05AX08
ATC
risperidone; systemic
10.7
25.5
28
27
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
4.3
25.4
68
168
N03AX12
ATC
[U] gabapentin; oral
3.2
25.3
112
389
G31.0
ICD-10 Finland
Circumscribed brain atrophy
+∞
25.1
24
*
XG416
NOMESCO Finland
Measurement of maximal airway pressure
+∞
25.1
24
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.4
25.0
221
1096
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
24.6
245
1279
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.4
24.0
225
1142
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
247.2
23.8
24
*
SPAT1254
SPAT
Administration of medicine
2.9
23.7
122
462
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
+∞
22.0
21
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.3
21.8
222
1162
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
226.0
21.7
22
*
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
118.3
21.7
23
*
T05
ICPC
Feeding problem of adult
44.7
21.5
26
6
G12.1
ICD-10 Finland
Other inherited spinal muscular atrophy
+∞
20.9
20
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
20.9
20
*
G20
ICD-10 Finland
Parkinson disease
215.4
20.7
21
*
NXL00
NOMESCO Finland
Biopsy of muscle
215.4
20.7
21
*
F80.1
ICD-10 Finland
Expressive language disorder
215.4
20.7
21
*
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
18.9
20.5
31
17
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
21.4
20.1
29
14
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
21.4
20.1
29
14
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
+∞
19.9
19
*
N06AX21
ATC
duloxetine; oral
4.1
19.8
56
144
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
29.8
19.7
26
9
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
18.3
19.7
30
17
GX2D5
NOMESCO Finland
Sleep oximetry
107.8
19.6
21
*
ACC51
NOMESCO Finland
Release of median nerve
47.3
19.3
23
5
N03AF01
ATC
carbamazepine; oral, rectal
6.2
19.2
33
55
SPAT1240
SPAT
Therapeutic discussion
4.9
19.1
43
92
G30.1
ICD-10 Finland
Alzheimer disease with late onset
56.5
19.0
22
*
JDB01
NOMESCO Finland
Laparoscopic gastrostomy
+∞
18.8
18
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
71.7
18.8
21
*
N06AA09
ATC
amitriptyline; systemic
3.8
18.6
59
165
S01.0
ICD-10 Finland
Open wound of scalp
3.5
18.3
65
196
Z2445
NOMESCO Finland
Psychologist
22.4
18.3
26
12
WX722
NOMESCO Finland
PEEP
5.5
17.9
35
66
Z3229
NOMESCO Finland
Other healthcare associate professional
3.0
17.7
81
286
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
17.5
153
743
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
5.5
17.0
33
62
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
64.8
16.8
19
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
4.0
16.6
49
130
XX9TE
NOMESCO Finland
Compementary ultrasound examination
28.2
16.6
22
8
R53
ICD-10 Finland
Malaise and fatigue
2.4
16.3
132
620
XG410
NOMESCO Finland
Flow-volume spirometry
4.1
16.2
45
114
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
14.9
15.9
26
18
Z50.5
ICD-10 Finland
Speech therapy
13.3
15.8
27
21
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
17.6
15.7
24
14
G71.9
ICD-10 Finland
Primary disorder of muscle, unspecified
+∞
15.7
15
*
RS314, ,
NOMESCO Finland
+∞
15.7
15
*
3352A
ICD-9 Finland
Anterior horn cell disease, Motor neuron disease[SCLEROSIS LATERALIS AMYOTROPHICA]
+∞
15.7
15
*
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
+∞
15.7
15
*
Z50.1
ICD-10 Finland
Other physical therapy
3.7
15.7
51
145
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
4.2
15.4
42
105
N05CF01
ATC
zopiclone; oral
2.0
15.3
202
1149
N05BA01
ATC
diazepam; systemic, rectal
2.8
15.2
80
304
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
23.9
15.2
21
9
R49.08
ICD-10 Finland
Other specified dysphonia
6.7
15.0
24
37
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.1
14.8
63
213
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.1
14.8
41
104
30041
ICD-8 Finland
Neuroses, Depressiva
+∞
14.6
14
*
R06.0
ICD-10 Finland
Dyspnoea
2.0
14.6
188
1057
G40.9
ICD-10 Finland
Epilepsy, unspecified
152.7
14.5
15
*
R47.0
ICD-10 Finland
Dysphasia and aphasia
152.7
14.5
15
*
N06AX16
ATC
venlafaxine; oral
3.6
14.5
49
143
N04BC05
ATC
pramipexole; oral
3.7
14.4
46
129
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
11.6
14.4
26
23
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
3.8
14.3
44
120
U04
ICPC
Incontinence urine
3.8
14.3
45
125
N06DA02
ATC
donepezil; oral
30.6
13.9
18
6
ZY010
NOMESCO Finland
Hospital outpatient
5.0
13.9
30
62
L99
ICPC
Musculoskeletal disease other
6.4
13.8
23
37
G62.8
ICD-10 Finland
Other specified polyneuropathies
76.5
13.6
15
*
L19
ICPC
Muscle symptom/complaint NOS
5.6
13.6
26
48
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
+∞
13.6
13
*
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
+∞
13.6
13
*
RK110, ,
NOMESCO Finland
16.5
13.5
21
13
M62.5
ICD-10 Finland
Muscle wasting and atrophy, not elsewhere classified
142.4
13.5
14
*
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
13.1
13.5
23
18
N03AG01
ATC
valproic acid; systemic, rectal
18.6
13.4
20
11
ABC60
NOMESCO Finland
Decompression of cervical spinal cord
26.3
13.4
18
7
SPAT1167
SPAT
Insertion of urinary catheter
4.3
13.3
35
85
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
14.1
13.3
22
16
K90
ICPC
Stroke/cerebrovascular accident
40.8
13.2
16
*
SPAT1262
SPAT
Handing over of treatment supplies
2.2
13.0
129
655
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
19.4
13.0
19
10
Z3226
NOMESCO Finland
Physiotherapist
2.1
12.9
131
672
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
12.5
12.7
22
18
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
15.7
12.7
20
13
G71.08
ICD-10 Finland
Other muscular dystrophy
+∞
12.5
12
*
N87
ICPC
Parkinsonism
+∞
12.5
12
*
R4120, ,
SPAT
24.8
12.5
17
7
J96.0
ICD-10 Finland
Acute respiratory failure
9.2
12.3
25
28
SPAT1301
SPAT
No procedures
1.8
12.1
209
1287
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
12.1
128
666
M48.0
ICD-10 Finland
Spinal stenosis
2.4
12.0
85
374
Z2446
NOMESCO Finland
Social worker
3.2
11.9
47
152
SPAT1139
SPAT
Nutrition survey
4.5
11.8
29
67
WYA20
NOMESCO Finland
Home visit
13.9
11.5
19
14
K11.72
ICD-10 Finland
Xerostomia
+∞
11.5
11
*
RS142, ,
NOMESCO Finland
+∞
11.5
11
*
G35
ICD-10 Finland
Multiple sclerosis
+∞
11.5
11
*
WX781
NOMESCO Finland
Remote monitoring, noninvasive ventilation
+∞
11.5
11
*
WX723
NOMESCO Finland
CPAP therapy
+∞
11.5
11
*
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
+∞
11.5
11
*
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
+∞
11.5
11
*
RS310, ,
NOMESCO Finland
+∞
11.5
11
*
J96.9
ICD-10 Finland
Respiratory failure, unspecified
15.3
11.3
18
12
N05AH03
ATC
olanzapine; systemic
15.3
11.3
18
12
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.7
11.2
62
242
N06DX01
ATC
memantine; oral
25.4
11.2
15
6
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
11.4
11.1
20
18
RS222, ,
NOMESCO Finland
14.1
11.0
18
13
RS340, ,
NOMESCO Finland
44.0
10.9
13
*
N05AN01
ATC
lithium; oral
44.0
10.9
13
*
R4110
NOMESCO Finland
Physiotherapy
1.8
10.9
201
1258
N03AX16
ATC
[U] pregabalin
2.0
10.9
126
677
UJC01
NOMESCO Finland
Scopy of lower throat
9.8
10.8
21
22
G56.2
ICD-10 Finland
Lesion of ulnar nerve
18.1
10.8
16
9
N06AB06
ATC
sertraline; oral
3.4
10.7
38
115
N07AA02
ATC
pyridostigmine; systemic
60.8
10.6
12
*
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
60.8
10.6
12
*
RS211, ,
NOMESCO Finland
60.8
10.6
12
*
N06AX26
ATC
vortioxetine; oral
5.4
10.6
21
40
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.4
10.6
26
60
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
9.3
10.6
21
23
Z93.1
ICD-10 Finland
Gastrostomy status
111.4
10.4
11
*
Z99.8
ICD-10 Finland
Dependence on other enabling machines and devices
111.4
10.4
11
*
R26.2
ICD-10 Finland
Difficulty in walking, not elsewhere classified
5.5
10.4
20
37
A120_, ,
NOMESCO Finland
+∞
10.4
10
*
85000
ICD-8 Finland
Concussion, Current or unspecified
+∞
10.4
10
*
A210_, ,
NOMESCO Finland
+∞
10.4
10
*
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
+∞
10.4
10
*
IGY02
NOMESCO Finland
Psychiatric monitoring contact
33.0
10.4
13
*
A98
ICPC
Health maint/preventive medicine
0.6
10.3
584
6582
W19
ICD-10 Finland
Unspecified fall
2.6
10.3
61
247
F03
ICD-10 Finland
Unspecified dementia
17.0
9.9
15
9
P29
ICPC
Psychological sympt/compl other
5.2
9.9
20
39
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
20.3
9.8
14
7
G44.2
ICD-10 Finland
Tension-type headache
2.9
9.8
47
170
A04
ICPC
Weakness/tiredness general
2.3
9.7
79
370
RS311, ,
NOMESCO Finland
55.7
9.7
11
*
RS122, ,
NOMESCO Finland
55.7
9.7
11
*
SPAT1276
SPAT
Outlining of treatment with patient or their family members
5.1
9.6
20
40
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
101.2
9.4
10
*
RS313, ,
NOMESCO Finland
101.2
9.4
10
*
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
30.4
9.4
12
*
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.4
9.4
43
1046
G71.00
ICD-10 Finland
Muscular dystrophy benign [Becker]
+∞
9.4
9
*
M41.4
ICD-10 Finland
Neuromuscular scoliosis
+∞
9.4
9
*
TJD10
NOMESCO Finland
Insertion of other tube into stomach or duodenum
+∞
9.4
9
*
ACC53
NOMESCO Finland
Release of ulnar nerve
+∞
9.4
9
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
+∞
9.4
9
*
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
+∞
9.4
9
*
WPA44
NOMESCO Finland
Nursing home for palliative care
+∞
9.4
9
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
9.4
9
*
G71.03
ICD-10 Finland
Muscular dystrophy autosomal recessive, childhood type, resembling Duchenne or Becker
+∞
9.4
9
*
M54.1
ICD-10 Finland
Radiculopathy
3.7
9.3
29
80
EB1VA, ,
NOMESCO Finland
0.2
9.3
8
424
RS221, ,
NOMESCO Finland
9.7
9.3
18
19
R41.0
ICD-10 Finland
Disorientation, unspecified
7.4
9.3
21
29
R06.5
ICD-10 Finland
Mouth breathing
2.9
9.2
42
148
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
37.1
9.0
11
*
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
7.6
9.0
20
27
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.1
8.9
93
480
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
5.0
8.9
19
39
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
6.7
8.7
21
32
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
50.6
8.7
10
*
JDB00
NOMESCO Finland
Gastrostomy
50.6
8.7
10
*
G25.9
ICD-10 Finland
Extrapyramidal and movement disorder, unspecified
50.6
8.7
10
*
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
16.5
8.6
13
8
RS230, ,
NOMESCO Finland
16.5
8.6
13
8
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
9.1
8.6
17
19
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
20.3
8.5
12
6
WPA43
NOMESCO Finland
A doctor's home visit to perform palliative care
91.0
8.4
9
*
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
91.0
8.4
9
*
G72.8
ICD-10 Finland
Other specified myopathies
91.0
8.4
9
*
N06DA03
ATC
rivastigmine; oral, transdermal
91.0
8.4
9
*
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
91.0
8.4
9
*
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
91.0
8.4
9
*
N05AX12
ATC
aripiprazole; systemic
91.0
8.4
9
*
SPAT1172
SPAT
Guidance concerning hydration
5.0
8.4
18
37
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
+∞
8.3
8
*
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
+∞
8.3
8
*
G61.8
ICD-10 Finland
Other inflammatory polyneuropathies
+∞
8.3
8
*
Z99.1
ICD-10 Finland
Dependence on respirator
+∞
8.3
8
*
G71.0
ICD-10 Finland
Muscular dystrophy
+∞
8.3
8
*
A220_, ,
NOMESCO Finland
+∞
8.3
8
*
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.2
8.3
32
102
Z02.4
ICD-10 Finland
Examination for driving licence
0.5
8.2
108
1796
WPA13
NOMESCO Finland
Palliative consultation
14.7
8.2
13
9
A29
ICPC
General symptom/complaint other
2.0
8.1
88
460
XA421
NOMESCO Finland
Nocturnal polygraphy
33.7
8.1
10
*
Z75.5
ICD-10 Finland
Holiday relief care
33.7
8.1
10
*
TNX05
NOMESCO Finland
Simple incision of soft tissue, unspecified region
33.7
8.1
10
*
F34.1
ICD-10 Finland
Dysthymia
33.7
8.1
10
*
Z43.1
ICD-10 Finland
Attention to gastrostomy
33.7
8.1
10
*
N03AX09
ATC
lamotrigine; oral
17.4
8.1
12
7
130
Kela drug reimbursment
Malignant tumour
0.2
7.9
15
581
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
4.5
7.9
19
43
N06AB03
ATC
fluoxetine; oral
2.5
7.7
49
205
WX1PA
NOMESCO Finland
Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)
45.4
7.7
9
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.6
7.7
43
169
G04BD12
ATC
mirabegron; oral
2.1
7.7
74
370
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.8
7.7
23
62
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
18.6
7.6
11
6
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
12.0
7.6
13
11
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.0
7.5
89
481
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.5
7.5
45
184
A06AH03
ATC
naloxegol; oral
4.5
7.5
18
41
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
80.8
7.4
8
*
N81
ICPC
Injury nervous system other
80.8
7.4
8
*
Z43.0
ICD-10 Finland
Attention to tracheostomy
80.8
7.4
8
*
RK320, ,
NOMESCO Finland
13.5
7.4
12
9
Z73.6
ICD-10 Finland
Limitation of activities due to disability
11.0
7.3
13
12
WX780
NOMESCO Finland
Remote monitoring CPAP
+∞
7.3
7
*
34800
ICD-8 Finland
Motor neurone disease, Amyotrophic lateral sclerosis
+∞
7.3
7
*
G99.2*M47.1
ICD-10 Finland
Spondylogenic compression of spinal cord
+∞
7.3
7
*
R27.0
ICD-10 Finland
Ataxia, unspecified
+∞
7.3
7
*
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
+∞
7.3
7
*
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
+∞
7.3
7
*
G12.0
ICD-10 Finland
Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]
+∞
7.3
7
*
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
+∞
7.3
7
*
H02AB13
ATC
deflazacort; oral
+∞
7.3
7
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.4
7.2
50
218
OAB50
NOMESCO Finland
Delivery of care equipment and instruction on their use
30.3
7.2
9
*
S62.3
ICD-10 Finland
Fracture of other metacarpal bone
4.1
7.1
19
47
N06AX03
ATC
mianserin; oral
4.1
7.1
19
47
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
7.1
70
354
N05AA02
ATC
levomepromazine; systemic
10.1
7.0
13
13
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.2
7.0
57
267
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
4.0
6.9
19
48
Z3231
NOMESCO Finland
Registered nurse
1.6
6.9
175
1179
H02AB02
ATC
dexamethasone; systemic
0.3
6.9
19
595
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.0
6.9
76
400
M03BX02
ATC
tizanidine; oral
1.5
6.9
369
2929
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
8.4
6.8
14
17
N05CD07
ATC
temazepam; oral
2.1
6.8
65
324
WPA42
NOMESCO Finland
Family-centered psychosocial intervention in palliative care
40.4
6.8
8
*
WPA40
NOMESCO Finland
Individual-centered psychosocial intervention in palliative care
40.4
6.8
8
*
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
6.8
50
225
G30.8
ICD-10 Finland
Other Alzheimer disease
22.7
6.7
9
*
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
6.5
6.7
16
25
XKD06
NOMESCO Finland
Physiologic investigation of micturition
3.5
6.6
22
64
F43.29
ICD-10 Finland
Adaptation disorder UNS
12.4
6.6
11
9
N05CD08
ATC
midazolam; nasal, systemic
4.2
6.6
17
41
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
10.1
6.5
12
12
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.4
6.5
45
196
P20
ICPC
Memory disturbance
2.2
6.5
56
268
L01BC06
ATC
capecitabine; oral
0.1
6.5
*
219
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.7
6.5
33
124
F29
ICD-10 Finland
Unspecified nonorganic psychosis
70.4
6.4
7
*
N04AA02
ATC
biperiden; systemic
70.4
6.4
7
*
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
70.4
6.4
7
*
GX1P5
NOMESCO Finland
Nocturnal CO2 monitoring
70.4
6.4
7
*
N04BD01
ATC
selegiline; oral
70.4
6.4
7
*
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
70.4
6.4
7
*
R63.4
ICD-10 Finland
Abnormal weight loss
2.8
6.4
30
108
SPAT1252
SPAT
Overall medication plan or its review
2.3
6.4
46
205
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
18.2
6.3
9
5
G51.0
ICD-10 Finland
Bell palsy
18.2
6.3
9
5
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.6
6.3
123
1855
R42
ICD-10 Finland
Dizziness and giddiness
1.7
6.3
120
751
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
+∞
6.3
6
*
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
+∞
6.3
6
*
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
+∞
6.3
6
*
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
+∞
6.3
6
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
6.3
6
*
G61.9
ICD-10 Finland
Inflammatory polyneuropathy, unspecified
+∞
6.3
6
*
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
+∞
6.3
6
*
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
+∞
6.3
6
*
A222_, ,
NOMESCO Finland
+∞
6.3
6
*
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
+∞
6.3
6
*
N86
ICPC
Multiple sclerosis
+∞
6.3
6
*
A123_, ,
NOMESCO Finland
+∞
6.3
6
*
RK410, ,
NOMESCO Finland
+∞
6.3
6
*
A211_, ,
NOMESCO Finland
+∞
6.3
6
*
N05BA09
ATC
clobazam; oral
+∞
6.3
6
*
WPA41
NOMESCO Finland
Psychosocial conversational support in palliative care
26.9
6.2
8
*
F06.7
ICD-10 Finland
Mild cognitive disorder
7.8
6.1
13
17
S28
ICPC
Limited function/disability (S)
8.7
6.1
12
14
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
3.5
6.0
20
58
SPAT1125
SPAT
Stoma care and guidance
5.2
6.0
17
33
RD210, ,
NOMESCO Finland
5.2
6.0
17
33
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
5.6
6.0
16
29
WW200, ,
SPAT
0.5
6.0
61
1108
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.9
6.0
17
44
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
95
21
51.29
163.35
1.1
1.8
8.13
34.71
e6/l
0.43
71
14
95
21
51.29
163.35
1.2
1.8
586.97
1018.33
e6/l
0.15
76
15
409
1176
6.14
143.25
2.5
1.7
443.80
200.23
u/l
1.58
393
1078
183
245
9.42
134.63
2.6
2.3
16.48
21.71
au/ml
—
8
16
169
223
9.37
125.39
1.3
1.2
67.80
50.64
au/ml
—
5
18
163
260
7.64
101.90
4.9
4.5
3.27
1.84
mmol/l
3.89
147
196
83
6
154.29
79.66
1.0
1.0
—
—
—
0
0
78
6
143.99
74.40
1.1
1.0
—
—
—
0
0
80
9
98.81
73.48
1.0
1.1
—
—
—
0
0
157
416
4.46
54.81
1.6
2.9
67.85
66.00
g/l
2.69
144
381
87
169
5.66
43.52
1.3
2.3
2.41
3.12
g/l
7.44
81
151
89
182
5.38
42.05
1.3
2.2
3.31
3.61
g/l
1.49
82
164
89
182
5.38
42.05
1.3
2.2
6.54
7.44
g/l
6.20
83
165
89
182
5.38
42.05
1.3
2.2
—
—
—
0
0
172
594
3.42
40.26
5.5
6.6
5.83
5.07
kpa
9.24
167
559
171
594
3.40
39.61
5.5
6.6
10.65
12.41
kpa
6.88
165
559
82
175
5.11
36.82
1.2
2.2
10.20
10.29
g/l
0.05
75
156
167
598
3.27
36.61
5.5
6.6
3.88
0.79
mmol/l
17.66
147
459
109
327
3.71
31.26
1.9
3.3
10.60
10.49
g/l
0.11
94
303
34
5
70.85
30.12
1.1
1.2
—
—
—
0
0
63
145
4.63
25.72
1.2
1.7
40.22
37.48
g/l
3.04
57
128
59
135
4.64
24.25
1.7
2.3
308.39
470.62
ug/l
0.40
52
127
361
2226
2.14
23.82
3.4
5.1
35.77
35.02
g/l
1.85
339
2072
59
137
4.57
23.81
1.4
1.7
0.00
0.03
g/l
0.75
53
124
64
161
4.24
23.32
1.4
2.0
0.71
1.20
g/l
0.30
56
133
57
135
4.47
22.43
1.2
1.7
0.00
0.00
g/l
-0.00
51
122
397
2594
2.07
21.89
5.9
6.7
1.22
1.21
mmol/l
3.23
332
2217
56
134
4.42
21.75
1.3
1.7
0.00
0.00
g/l
-0.00
50
122
68
191
3.80
21.29
1.7
2.0
38.24
39.05
u/l
0.12
63
161
174
842
2.37
20.36
1.7
1.6
1156.05
1133.00
nmol/l
0.12
136
626
168
804
2.38
20.14
1.7
1.8
—
—
—
0
0
45
100
4.71
19.14
2.7
2.3
18.54
15.73
%
5.18
34
47
165
807
2.32
18.70
2.5
3.9
0.83
0.82
mmol/l
0.35
147
753
355
2363
1.91
17.27
6.1
5.8
1.21
1.21
mmol/l
0.85
326
2159
429
3056
1.88
16.73
4.9
4.2
6.43
6.80
mmol/l
4.62
413
2844
491
5979
0.53
15.88
3.9
4.7
2.82
2.76
mmol/l
0.62
421
5416
111
492
2.46
15.53
1.8
2.5
0.23
0.21
g/l
1.99
106
467
480
5855
0.54
14.94
3.7
4.2
4.75
4.65
mmol/l
1.11
411
5342
40
99
4.20
14.87
2.5
2.1
144.09
128.39
g/l
3.81
35
64
476
5813
0.54
14.72
3.7
4.1
1.49
1.46
mmol/l
0.61
408
5269
23
37
6.37
13.80
1.0
1.8
—
—
—
0
0
308
2079
1.79
13.41
1.8
1.8
94.36
94.11
pmol/l
0.03
168
1042
116
558
2.26
13.41
1.7
1.6
—
—
—
0
0
357
2534
1.75
12.93
14.3
16.3
1.23
1.37
inr
2.04
95
682
465
5615
0.58
11.91
3.4
3.8
1.25
1.24
mmol/l
0.01
395
5050
112
561
2.16
11.67
1.7
1.7
—
—
—
0
0
70
1466
0.43
10.87
1.6
1.6
1.33
1.28
mmol/l
0.26
63
1198
174
1046
1.85
10.75
1.4
1.6
453.09
37863362.80
pmol/l
1.25
145
861
100
516
2.07
9.60
3.9
4.1
4.04
1.67
mmol/l
6.23
92
405
119
672
1.91
8.82
4.1
5.6
1.04
1.07
mmol/l
0.50
109
626
15
13
11.74
8.59
1.0
4.4
33.97
28.92
umol/l
0.97
15
13
13
8
16.50
8.57
1.3
2.1
4.64
5.35
mmol/l
—
13
8
337
2542
1.57
8.51
4.7
6.1
26.44
27.49
%
0.88
320
2369
329
2497
1.54
7.93
4.6
5.8
59.08
57.23
%
1.92
315
2326
167
1079
1.69
7.84
1.4
1.5
20.30
20.00
nmol/l
0.11
152
884
15
16
9.53
7.80
3.9
2.4
71.31
61.51
ug/l
0.18
15
16
14
14
10.16
7.55
1.0
1.1
—
—
—
0
0
62
295
2.20
7.32
6.6
8.7
26.83
24.51
mmol/l
5.68
57
284
465
5401
0.66
7.18
4.7
5.4
38.27
39.82
mmol/mol
3.88
415
4923
235
1697
1.55
6.89
2.8
4.1
2.37
2.36
mmol/l
1.15
207
1482
121
1858
0.59
6.69
3.1
3.7
8.50
7.76
mg/mmol
0.09
70
1167
250
1849
1.52
6.51
4.2
3.1
58.84
85.98
ng/l
0.46
223
1313
608
6640
0.63
6.37
22.3
18.1
244.87
242.81
e9/l
0.37
591
6390
609
6645
0.64
6.28
22.4
18.2
135.62
136.09
g/l
0.35
602
6495
608
6635
0.64
6.25
22.7
18.2
40.24
40.09
%
0.21
557
6132
507
5738
0.68
6.24
4.0
4.3
5.84
5.94
mmol/l
1.42
453
5148
609
6643
0.64
6.24
22.2
18.1
4.46
4.50
e12/l
0.95
588
6365
10
8
12.64
6.09
1.1
1.0
—
—
—
0
0
10
8
12.64
6.09
1.1
1.0
—
—
—
0
0
94
558
1.78
5.90
4.0
2.7
—
—
—
0
0
32
125
2.63
5.86
1.5
1.6
—
—
—
0
0
411
3433
1.41
5.35
5.2
3.7
46.00
2800.88
e6/l
—
8
49
466
3980
1.42
5.33
3.9
3.7
10.90
13.23
mm/h
3.29
437
3635
9
9
10.10
5.03
1.1
1.0
—
—
—
0
0
20
66
3.08
4.97
2.0
1.2
5.97
8.35
u/l
0.49
12
51
211
1582
1.46
4.93
2.8
3.3
42.02
41.44
u/l
0.03
204
1504
379
3157
1.39
4.83
6.1
9.3
4.06
4.07
e9/l
0.04
327
2688
66
375
1.83
4.81
3.9
3.9
63.44
92.25
ng/l
2.62
59
340
8
7
11.53
4.79
2.5
1.6
—
—
—
0
0
496
5543
0.72
4.68
13.6
12.3
92.74
76.31
ml/min/173m2
25.83
409
4434
8
8
10.09
4.52
1.3
1.0
—
—
—
0
0
111
1605
0.64
4.52
2.5
3.2
0.83
0.84
ug/l
0.07
82
1108
60
338
1.84
4.50
1.6
2.4
420.77
392.59
nmol/l
0.59
52
316
53
289
1.89
4.40
4.4
4.5
26.33
23.74
mmol/l
4.99
53
284
9
12
7.57
4.36
1.0
1.0
—
—
—
0
0
585
6338
0.70
4.32
9.6
9.6
36.14
25.66
u/l
4.24
565
6044
31
139
2.28
4.30
1.4
1.2
—
—
—
0
0
41
206
2.04
4.29
1.7
2.0
—
—
—
0
0
8
9
8.96
4.28
1.1
1.0
—
—
—
0
0
14
41
3.46
4.20
1.3
1.0
—
—
—
0
0
37
181
2.10
4.16
1.6
1.9
—
—
—
0
0
7
7
10.07
4.01
1.1
1.0
—
—
—
0
0
7
7
10.07
4.01
1.0
1.0
—
—
—
0
0
54
307
1.81
3.96
1.7
1.5
—
—
—
0
0
250
2000
1.37
3.89
2.6
2.2
78.72
79.50
nmol/l
0.15
217
1770
57
337
1.75
3.68
9.2
8.4
91.49
94.02
%
1.34
57
337
129
1739
0.69
3.60
2.5
3.2
9646.70
202.61
mg/l
4.93
84
1108
134
1786
0.70
3.50
2.9
3.0
7.13
7.54
mmol/l
0.51
105
1478
7
10
7.05
3.37
1.0
1.0
—
—
—
0
0
331
2808
1.31
3.34
4.7
7.0
12.33
12.96
umol/l
0.36
317
2662
438
3865
1.30
3.26
3.3
3.4
15.27
14.95
pmol/l
1.82
408
3430
56
342
1.69
3.25
1.5
1.5
—
—
—
0
0
24
110
2.22
3.22
1.1
1.1
—
—
—
0
0
58
360
1.66
3.17
1.4
1.5
1.41
1.37
%
0.16
49
312
7
13
5.42
2.87
1.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
9
6.71
2.87
1.0
1.0
—
—
—
0
0
135
1039
1.36
2.61
3.5
3.3
748.88
752.29
ng/l
0.00
117
867
5
7
7.18
2.55
1.0
1.0
—
—
—
0
0
72
497
1.49
2.54
3.3
2.7
153.23
228.10
ng/l
1.15
66
451
368
3245
1.25
2.51
3.2
2.7
38.36
51.03
u/l
4.36
344
2963
10
32
3.15
2.44
1.9
4.5
—
—
—
0
0
181
2193
0.77
2.39
3.8
4.5
22.20
21.71
%
0.21
100
1181
5
8
6.28
2.37
2.4
1.9
31984.40
24431.00
ug/l
—
5
8
8
22
3.66
2.37
1.1
1.0
—
—
—
0
0
19
92
2.09
2.28
1.4
1.2
—
—
—
0
0
229
2684
0.79
2.28
3.9
5.4
5.89
3.74
ug/l
0.37
197
2412
47
701
0.65
2.19
2.6
5.0
12.80
42.06
ug/l
1.02
38
591
22
115
1.94
2.17
4.1
5.0
68.32
63.11
%
0.66
22
115
6
14
4.31
2.15
1.7
2.1
—
—
—
0
0
15
68
2.23
2.12
2.5
1.9
1.42
1.61
mmol/l
0.83
15
68
20
102
1.99
2.12
1.3
1.2
—
—
—
0
0
20
102
1.99
2.12
1.3
1.2
—
—
—
0
0
8
25
3.22
2.10
1.3
2.0
—
—
—
0
0
60
417
1.47
2.09
2.3
4.2
1.22
1.23
mmol/l
0.86
48
369
197
1650
1.26
2.04
3.0
2.9
973.53
1560.77
ng/l
1.83
164
1429
120
943
1.32
2.04
2.8
3.4
2.47
2.46
mmol/l
0.30
102
830
198
1661
1.26
2.02
3.5
3.2
48.38
76.16
e6/l
0.59
154
1274
19
97
1.98
2.01
1.6
1.4
—
—
—
0
0
133
1066
1.30
1.96
1.8
1.6
1.28
1.38
mg/l
0.19
106
820
28
457
0.60
1.95
1.7
1.7
—
—
—
0
0
181
1516
1.25
1.87
3.5
3.2
0.79
0.58
e6/l
0.39
141
1143
9
34
2.67
1.87
1.8
1.3
—
—
—
0
0
9
35
2.59
1.80
1.8
1.3
—
—
—
0
0
467
4320
1.20
1.73
6.0
7.5
72.92
81.44
u/l
6.49
438
4035
6
146
0.41
1.65
1.5
3.2
12.85
986.90
u/ml
—
6
136
228
1984
1.21
1.63
3.7
3.1
—
—
—
0
0
29
182
1.62
1.62
1.8
2.4
—
—
—
0
0
16
84
1.92
1.60
2.1
4.0
57.44
56.46
%
0.09
16
84
120
1459
0.79
1.59
2.6
2.7
9452.65
7550.84
umol/l
0.14
101
1281
10
43
2.34
1.59
1.1
1.1
—
—
—
0
0
12
57
2.12
1.55
1.2
1.7
—
—
—
0
0
132
1092
1.25
1.52
3.0
2.5
6.92
5.84
e6/l
0.24
117
974
24
146
1.66
1.52
1.4
1.6
—
—
—
0
0
6
21
2.87
1.51
2.5
1.1
—
—
—
0
0
13
65
2.02
1.49
2.2
1.9
89.40
89.23
%
0.03
13
65
60
448
1.37
1.47
2.7
2.2
12.34
7.45
ug/l
0.41
53
406
6
22
2.74
1.43
1.5
1.7
196.67
210.41
u/l
—
6
22
113
925
1.26
1.43
1.2
1.2
0.78
1.38
u/ml
1.41
21
224
16
88
1.84
1.42
1.8
1.4
—
—
—
0
0
14
74
1.91
1.39
1.7
1.4
—
—
—
0
0
12
60
2.02
1.38
1.1
1.6
—
—
—
0
0
12
60
2.02
1.38
1.1
1.6
—
—
—
0
0
12
60
2.02
1.38
1.1
1.6
—
—
—
0
0
39
273
1.45
1.38
1.4
1.4
—
—
—
0
0
15
82
1.85
1.36
1.9
3.7
3.92
4.03
e9/l
0.11
15
82
6
24
2.51
1.30
1.2
1.8
—
—
—
0
0
6
24
2.51
1.30
1.2
1.8
—
—
—
0
0
18
106
1.71
1.30
1.2
1.2
—
—
—
0
0
5
18
2.79
1.28
3.2
1.9
—
—
—
0
0
5
18
2.79
1.28
3.2
1.9
—
—
—
0
0
10
48
2.10
1.28
1.3
1.3
—
—
—
0
0
11
55
2.01
1.27
1.2
1.7
—
—
—
0
0
22
138
1.61
1.27
1.5
1.6
—
—
—
0
0
524
4960
1.17
1.27
4.0
3.9
1.91
2.34
mu/l
1.04
484
4384
8
35
2.30
1.27
1.1
1.8
—
—
—
0
0
8
35
2.30
1.27
1.1
1.8
—
—
—
0
0
8
35
2.30
1.27
1.0
1.1
—
—
—
0
0
18
107
1.70
1.26
1.3
1.7
—
—
—
0
0
18
107
1.70
1.26
1.3
1.7
—
—
—
0
0
6
25
2.41
1.24
1.2
1.8
—
—
—
0
0
592
6156
0.85
1.22
18.4
14.5
3.93
4.00
mmol/l
6.49
577
5939
5
19
2.64
1.21
1.0
1.2
—
—
—
0
0
591
6143
0.85
1.19
18.5
14.3
139.70
139.75
mmol/l
0.17
580
5942
14
79
1.79
1.17
1.8
1.4
—
—
—
0
0
5
21
2.39
1.09
1.2
2.2
—
—
—
0
0
9
46
1.97
1.04
3.4
2.4
—
—
—
0
0
7
135
0.51
0.99
1.4
1.2
—
—
—
0
0
7
37
1.90
0.94
2.3
1.4
—
—
—
0
0
44
563
0.77
0.93
1.4
1.4
—
—
—
0
0
16
103
1.56
0.88
1.5
1.6
—
—
—
0
0
6
30
2.01
0.87
2.5
1.5
—
—
—
0
0
6
30
2.01
0.87
2.5
1.5
—
—
—
0
0
6
30
2.01
0.87
5.2
3.3
24.33
19.31
nmol/l
—
6
30
90
765
1.20
0.85
1.2
1.2
34.91
42.26
iu/ml
0.13
23
238
6
31
1.94
0.84
1.0
1.2
—
—
—
0
0
11
66
1.68
0.79
1.0
1.2
—
—
—
0
0
0
28
0.00
0.76
0.0
1.0
—
—
—
0
0
60
720
0.82
0.76
1.2
1.2
9.06
17.68
u/ml
0.75
23
266
17
116
1.48
0.74
1.4
1.3
—
—
—
0
0
154
1384
1.14
0.74
4.0
3.3
0.00
0.01
estimate
0.50
52
424
15
100
1.51
0.73
1.3
1.3
—
—
—
0
0
82
705
1.18
0.71
7.6
6.1
—
—
—
0
0
95
828
1.17
0.70
1.8
2.4
14.27
12.78
umol/l
0.88
84
781
7
43
1.63
0.67
1.0
1.4
—
114.29
—
0
7
5
95
0.52
0.66
1.6
1.5
—
—
—
0
0
8
129
0.62
0.64
1.3
1.2
—
—
—
0
0
109
969
1.14
0.63
3.0
2.8
1.27
1.02
e6/l
0.33
77
572
8
49
1.64
0.62
1.1
1.1
—
—
—
0
0
5
30
1.67
0.61
1.8
1.3
—
—
—
0
0
20
151
1.33
0.54
1.6
1.5
0.58
0.12
iu/ml
—
5
36
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
187
1.29
0.53
2.8
2.6
0.35
0.31
u/ml
0.30
15
103
19
143
1.34
0.53
4.3
4.9
1.09
1.57
mg/l
2.30
19
129
9
63
1.43
0.52
2.9
4.5
—
—
—
0
0
6
98
0.61
0.52
2.2
5.8
—
421.67
—
0
12
6
40
1.50
0.51
1.8
1.4
—
—
—
0
0
6
40
1.50
0.51
1.0
1.5
—
—
—
0
0
15
110
1.37
0.49
2.1
1.3
24.49
34.97
iu/l
—
10
95
10
141
0.71
0.45
1.2
1.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
0.92
—
0
6
5
35
1.43
0.39
1.6
2.1
—
—
—
0
0
581
5698
1.07
0.38
16.1
12.2
25.05
28.09
mg/l
1.10
502
4277
5
37
1.35
0.37
1.0
1.2
—
—
—
0
0
9
70
1.29
0.36
1.1
1.4
—
—
—
0
0
5
77
0.65
0.36
1.0
1.1
—
—
—
0
0
30
255
1.18
0.35
1.1
1.2
103.31
154.64
iu/ml
—
8
87
63
567
1.12
0.34
2.2
2.9
7.62
9.40
umol/l
0.48
53
499
208
1982
1.07
0.33
2.4
2.6
138.52
167.66
ug/l
1.50
190
1811
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
80
733
1.10
0.32
1.7
2.4
23.42
22.88
%
0.14
71
643
10
74
1.36
0.32
1.4
1.6
—
—
—
0
0
10
74
1.36
0.32
1.4
1.6
—
—
—
0
0
119
1115
1.08
0.30
3.7
3.3
1.01
1.02
kg/l
0.83
24
152
8
63
1.27
0.28
1.9
1.5
—
—
—
0
0
41
458
0.89
0.27
2.6
2.3
29.15
36.35
u/l
1.06
33
392
16
131
1.23
0.27
1.9
1.4
—
—
—
0
0
99
926
1.08
0.27
3.2
3.0
1.51
1.66
e6/l
0.11
66
533
40
447
0.89
0.27
1.9
2.8
120.62
59.11
ml/min/173m2
0.76
13
171
209
2007
1.06
0.26
3.9
3.3
—
—
—
0
0
5
74
0.67
0.26
1.0
1.1
1.70
1.54
g/l
—
5
68
83
773
1.08
0.25
1.6
2.3
2.25
2.27
g/l
0.12
71
725
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
8
101
0.79
0.21
1.1
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
6
50
1.20
0.19
1.2
1.3
5.50
13.82
u/l
—
6
45
10
81
1.24
0.19
1.7
1.5
—
—
—
0
0
38
414
0.91
0.18
1.9
1.9
10.08
12.60
nmol/l
1.06
33
363
21
185
1.14
0.18
2.2
1.3
—
—
—
0
0
16
138
1.16
0.17
1.3
1.1
—
—
—
0
0
16
138
1.16
0.17
1.3
1.1
—
—
—
0
0
17
150
1.14
0.14
2.2
2.3
90.29
86.33
%
0.30
17
145
160
1553
1.04
0.14
2.3
2.3
52.40
62.28
u/l
2.06
146
1419
12
139
0.86
0.14
1.8
1.6
—
—
—
0
0
10
84
1.19
0.14
1.2
1.2
—
—
—
0
0
17
152
1.12
0.12
3.0
2.7
3.56
3.64
g/l
0.06
17
144
23
210
1.10
0.12
2.1
1.4
—
—
—
0
0
257
2611
0.98
0.10
5.2
4.3
0.00
0.00
estimate
-0.00
53
450
10
87
1.15
0.09
1.1
1.9
14.26
27.95
ug/l
—
10
87
67
646
1.04
0.09
1.3
1.4
—
—
—
0
0
132
1291
1.03
0.08
2.1
2.2
3.10
2.87
mg/l
0.48
106
1084
21
226
0.93
0.08
1.1
1.0
—
—
—
0
0
7
68
1.03
0.08
2.6
1.3
—
—
—
0
0
6
70
0.86
0.07
1.5
1.4
—
—
—
0
0
6
70
0.86
0.07
1.5
1.4
—
—
—
0
0
15
137
1.10
0.07
2.3
2.3
12.83
70.23
ug/min
—
6
79
291
2943
0.98
0.07
2.7
2.3
—
—
—
0
0
13
142
0.91
0.06
1.5
1.4
—
—
—
0
0
263
2603
1.02
0.06
3.8
3.1
0.00
0.00
estimate
0.50
55
480
134
1359
0.98
0.04
2.0
2.5
—
—
—
0
0
19
180
1.06
0.04
1.9
4.4
37.83
41.43
mg/l
0.10
14
155
267
2651
1.01
0.03
3.7
3.1
0.00
0.00
estimate
-0.00
52
442
14
132
1.06
0.02
1.1
1.3
—
—
—
0
0
13
138
0.94
0.02
2.2
1.8
—
—
—
0
0
12
113
1.06
0.02
1.5
1.5
50.58
40.47
nmol/l
0.63
12
107
261
2599
1.01
0.01
2.1
2.6
—
—
—
0
0
22
213
1.03
0.01
1.3
1.2
—
—
—
0
0
69
694
0.99
0.00
3.7
4.1
34.34
32.49
%
0.63
41
419
16
159
1.01
0.00
4.1
3.1
24.20
30.01
mg/l
—
10
97
18
181
0.99
0.00
2.0
4.4
35.36
85.59
mg/l
0.80
13
153
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
6
69
0.87
-0.00
1.5
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
36.92
—
0
6
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
6.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
23.83
—
0
6
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
9
96
0.94
-0.00
1.3
1.3
—
—
—
0
0
6
69
0.87
-0.00
1.5
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
3.7
—
6.44
—
0
7
0
6
0.00
-0.00
0.0
1.2
—
22.72
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
70
1.00
-0.00
1.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
9.12
—
0
6
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
81
0.99
-0.00
2.4
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
9.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
6.3
—
31.50
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.0
—
0.00
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
114.71
—
0
7
6
69
0.87
-0.00
1.5
1.4
—
—
—
0
0
6
69
0.87
-0.00
1.5
1.4
—
—
—
0
0
8
86
0.93
-0.00
1.3
1.5
—
172.84
—
0
14
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
10.17
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: MND – Motor neuron disease (with DMD)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).